Feasibility of chemotherapy and regional hyperthermia in patients with intermediate/high risk non-muscle invasive transitional cell carcinoma of the bladder
- Conditions
- non invasive bladder cancer non invasive urothelial cell carcinoma of the bladder1003836410004994
- Registration Number
- NL-OMON32637
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Patients with intermediate/ high risk Ta-1 grade 3 or Ta-1 grade 2 recurrent or carcinoma in situ (CIS) non-muscle invasive transitional cell carcinoma of the bladder.
Exclusion Criteria
*Intravesical (Mitomycin C) MMC during the last 12 months
*Bladder tumors other than transitional cel carcinoma
*Known allergy to MMC
*Small bladder volume; less than 100 cc measured by uroflowmetry
*Residual urine > 100 cc measured by ultrasound
*A history of muscle invasive carcinoma of the bladder
*Urinary incontinence
*Hip prosthesis
*Pacemaker
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method